CBS 2019
CBSMD教育中心
English

Acute Coronary Syndrom

科研文章

荐读文献

The year in cardiovascular medicine 2020: acute coronary syndromes and intensive cardiac care The Wait for High-Sensitivity Troponin Is Over—Proceed Cautiously Symptom onset-to-balloon time and mortality in the first seven years after STEMI treated with primary percutaneous coronary intervention 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network) Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS
|<<... 8 9 10 11 12 13 14 ...>>|

Original ResearchVolume 11, Issue 12, December 2018

JOURNAL：JACC Cardiovasc Imaging. Article Link

Long-Term Prognostic Implications of Previous Silent Myocardial Infarction in Patients Presenting With Acute Myocardial Infarction

RP Amier, MW Smulders, R Nijveldt et al. Keywords: acute myocardial infarction; cardiovascular magnetic resonance; late gadolinium enhancement; prognosis; unrecognized myocardial infarction

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top